Arix today announces the following updates to its Board and Executive team
LONDON, 6 October 2021: Arix Bioscience plc (“Arix” or the…
Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer
Industry veteran with decades of experience in company formation,…
Amber Implants VCFix® spinal system receives US FDA Breakthrough Designation
The Hague, Netherlands, 5 October 2021: Amber Implants, an innovative…
DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric Healthcare
DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric…
ExeVir Bio BV announces its participation in the 8th Annual Healthtech Investment Forum organized by SACHS Associates taking place virtually 5th-6th October 2021.
Torsten Mummenbrauer, Chief Executive Officer of ExeVir will…
Versameb at Sachs 21st Annual Biotech in Europe Forum
Isabel Ferreira speaking on the “Platform Technologies and…
Arix Bioscience plc Interim results for the six months ended 30 June 2021
LONDON, 12 August 2021: Arix Bioscience plc (“Arix”, LSE:…
Novo Holdings posts record income and returns of DKK 29 billion (EUR 4 billion) in 2020
Novo Holdings’ 2020 result is based on a strong performance…
Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:…
Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer
Key hires enhance management for next development phase
09 January…
Ori Biotech announces a $9.4M seed round to advance innovation in Cell and Gene Therapy manufacturing
Syndicate includes leading UK investors Amadeus Capital Partners,…
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
LONDON, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:…
Edinburgh Molecular Imaging Closes Financing
To accelerate development of molecular targeted systemic radiotherapy…
Forendo Pharma signs important License and Collaboration Deal with Leading Pharma Company
Forendo Pharma, a clinical stage drug development company focusing…
STORM Therapeutics’ collaborator awarded ASH–BSH Abstract Achievement Award at the 61st ASH Annual Meeting & Exposition
09 December 2019, Cambridge, UK: STORM Therapeutics, the biotechnology…
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
We are specialists with an indepth understanding of how to communicate complex science to investors and corporate stakeholders. We help companies on their journey as they grow and have been trusted by hundreds of clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York